{"id":277039,"date":"2026-08-26T19:52:13","date_gmt":"2026-08-26T19:52:13","guid":{"rendered":"https:\/\/www.europesays.com\/ro\/277039\/"},"modified":"2026-08-26T19:52:13","modified_gmt":"2026-08-26T19:52:13","slug":"nu-va-puneti-prin-inactiune-semnatura-pe-certificatele-noastre-de-deces-pacientii-cu-cancer-il-contrazic-pe-seful-cnas","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ro\/277039\/","title":{"rendered":"\u201eNu v\u0103 pune\u021bi, prin inac\u021biune, semn\u0103tura pe certificatele noastre de deces\u201d. Pacien\u021bii cu cancer \u00eel contrazic pe \u0219eful CNAS"},"content":{"rendered":"<p>Declara\u021bia pre\u0219edintelui CNAS, Hora\u021biu Moldovan, potrivit c\u0103reia medicamentele pentru bolnavii de cancer sunt disponibile este contrazis\u0103 de asocia\u021biile de pacien\u021bi, care reclam\u0103 lipsuri \u0219i discontinuit\u0103\u021bi \u00een aprovizionarea cu citostatice. Reprezentan\u021bii pacien\u021bilor avertizeaz\u0103 c\u0103 \u00eent\u00e2rzierile pot duce la am\u00e2narea tratamentelor, \u00een timp ce unii bolnavi ajung s\u0103 \u00ee\u0219i cumpere singuri medicamentele din str\u0103in\u0103tate.<\/p>\n<p> <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/ro\/wp-content\/uploads\/2026\/08\/1787773933_790_index.jpeg\" alt=\"FABC solicit\u0103 publicarea transparent\u0103 a situa\u021biei stocurilor de medicamente pentru cancer\" width=\"1125\" height=\"750\" loading=\"eager\" fetchpriority=\"high\" class=\"svelte-1kfbksm\"\/> <\/p>\n<p>FABC solicit\u0103 publicarea transparent\u0103 a situa\u021biei stocurilor de medicamente pentru cancer Foto: Pexel<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Reprezentan\u021bii Federa\u021biei Asocia\u021biilor Bolnavilor de Cancer din Rom\u00e2nia (FABC) lanseaz\u0103 un apel c\u0103tre premier \u0219i pre\u0219edintele Casei Na\u021bionale de Asigur\u0103ri de S\u0103n\u0103tate (CNAS), acuz\u00e2nd lipsa unor medicamente oncologice \u0219i discontinuit\u0103\u021bi repetate \u00een aprovizionare. Organiza\u021bia sus\u021bine c\u0103, \u00een doar 24 de ore, a identificat trei medicamente care lipsesc \u0219i alte opt pentru care exist\u0103 probleme repetate de disponibilitate.<\/p>\n<p>\u201eAceasta este realitatea din spitale \u0219i din via\u021ba pacien\u021bilor\u201d, transmit reprezentan\u021bii pacien\u021bilor, \u00eentr-o scrisoare adresat\u0103 premierului \u0219i conducerii CNAS.<\/p>\n<p>Apelul vine dup\u0103 declara\u021biile publice potrivit c\u0103rora \u00een oncologie nu ar exista lipsuri de medicamente, ci doar situa\u021bii \u00een care anumite tratamente sunt mai greu de achizi\u021bionat.<\/p>\n<p>Potrivit FABC, \u00eentreruperile sau \u00eent\u00e2rzierile \u00een aprovizionare pot avea consecin\u021be grave pentru pacien\u021bii cu cancer, deoarece pot duce la am\u00e2narea tratamentelor.<\/p>\n<p>\u201ePentru un pacient cu cancer, o discontinuitate de c\u00e2teva s\u0103pt\u0103m\u00e2ni nu \u00eenseamn\u0103 o simpl\u0103 problem\u0103 de aprovizionare. \u00censeamn\u0103 tratament am\u00e2nat, boal\u0103 care poate progresa, \u0219anse terapeutice pierdute \u0219i, uneori, vie\u021bi pierdute\u201d, avertizeaz\u0103 organiza\u021bia.<\/p>\n<p> \u201eExist\u0103 riscul ca accesul la tratamente s\u0103 fie restr\u00e2ns?\u201d <\/p>\n<p>Federa\u021bia condus\u0103 de Cezar Irimia ridic\u0103 \u0219i problema resurselor financiare din sistem \u0219i cere autorit\u0103\u021bilor s\u0103 spun\u0103 clar dac\u0103 exist\u0103 riscul ca accesul pacien\u021bilor oncologici la tratamente s\u0103 fie restr\u00e2ns sau am\u00e2nat din lips\u0103 de fonduri.<\/p>\n<p>\u201ePacien\u021bii au dreptul la un r\u0103spuns clar\u201d, se arat\u0103 \u00een apel.<\/p>\n<p>Reprezentan\u021bii bolnavilor mai sus\u021bin c\u0103 unele medicamente au fost deja evaluate \u0219i introduse prin acte normative \u00een sistemul de compensare, \u00eens\u0103 pacien\u021bii nu au acces efectiv la ele din cauza \u00eent\u00e2rzierilor administrative sau birocratice.<\/p>\n<p>\u201ePentru administra\u021bie, acestea pot fi proceduri, termene \u0219i documente. Pentru pacientul oncologic, timpul se m\u0103soar\u0103 \u00een \u0219anse de supravie\u021buire\u201d, transmite FABC.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Ce solicit\u0103 pacien\u021bii <\/p>\n<p>Organiza\u021bia cere autorit\u0103\u021bilor o verificare de urgen\u021b\u0103, la nivel na\u021bional, a disponibilit\u0103\u021bii medicamentelor oncologice, inclusiv a celor pentru care au existat discontinuit\u0103\u021bi repetate.<\/p>\n<p>De asemenea, FABC solicit\u0103 publicarea transparent\u0103 a situa\u021biei stocurilor \u0219i a discontinuit\u0103\u021bilor, identificarea rapid\u0103 a solu\u021biilor de aprovizionare, clarificarea situa\u021biei terapiilor aprobate, dar care nu sunt \u00eenc\u0103 accesibile pacien\u021bilor, precum \u0219i crearea unui mecanism permanent de dialog cu organiza\u021biile de pacien\u021bi.<\/p>\n<p>Mesajul final al scrisorii este unul dur, reprezentan\u021bii bolnavilor avertiz\u00e2nd asupra consecin\u021belor pe care lipsa tratamentelor le poate avea.<\/p>\n<p>\u201eCancerul nu a\u0219teapt\u0103. \u0218i nici pacien\u021bii nu mai pot a\u0219tepta\u201d, transmit ace\u0219tia, cer\u00e2nd autorit\u0103\u021bilor s\u0103 nu permit\u0103 ca \u201elipsa medicamentelor, subfinan\u021barea sau \u00eent\u00e2rzierile administrative s\u0103 decid\u0103 cine prime\u0219te la timp \u0219ansa la tratament \u0219i cine nu\u201d.<\/p>\n<p>\u201eNu v\u0103 pune\u021bi, prin inac\u021biune, semn\u0103tura pe certificatele noastre de deces\u201d, este avertismentul transmis de Cezar Irimia, pre\u0219edintele Federa\u021biei Asocia\u021biilor Bolnavilor de Cancer din Rom\u00e2nia.<\/p>\n<p> \u201ePacien\u021bii sunt \u00een chinuri f\u0103r\u0103 acest medicament\u201d <\/p>\n<p>La r\u00e2ndul lui, Vasile Barbu, pre\u0219edintele Asocia\u021biei Na\u021bionale pentru Protec\u021bia Pacien\u021bilor, a explicat pentru \u201eAdev\u0103rul\u201d c\u0103 principalele dificult\u0103\u021bi sunt legate de medicamentele citostatice care nu sunt prescrise \u00een mod obi\u0219nuit de oncologi, adic\u0103 cele off-label.\u00a0<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>\u201eProblemele principale sunt legate de medicamentele citostatice care nu sunt prescrise \u00een mod obi\u0219nuit de oncologi, adic\u0103 cele off-label. De asemenea, \u00een cazul unui medicament generic, produs de cinci produc\u0103tori diferi\u021bi \u2013 at\u00e2t \u00een Rom\u00e2nia, c\u00e2t \u0219i \u00een str\u0103in\u0103tate \u2013 \u00een trecut, ministerul S\u0103n\u0103t\u0103\u021bii nu a r\u0103spuns la notificarea companiei produc\u0103toare, care a anun\u021bat c\u0103 nu va putea livra timp de aproximativ opt luni din cauza unor probleme tehnologice, dar \u0219i a unor blocaje \u00een aprovizionarea cu materie prim\u0103 din Pakistan, India sau chiar cu folie de aluminiu din China, iar acum \u0219i din cauza r\u0103zboiului din Iran.\u00a0<\/p>\n<p>De\u0219i \u00een Europa existau alte variante ale aceluia\u0219i medicament, iar Ministerul S\u0103n\u0103t\u0103\u021bii ar fi putut apela, prin Unifarm, la un sistem de urgen\u021b\u0103 pentru a-l procura, acest lucru nu s-a \u00eent\u00e2mplat, iar lipsa lui a provocat o suferin\u021b\u0103 enorm\u0103 pentru cei 10.000\u201312.000 de pacien\u021bi care primesc lunar citostatice, pentru care acest medicament atenua grea\u021ba insuportabil\u0103 \u0219i starea de r\u0103u, amelior\u00e2nd calitatea vie\u021bii. Practic, ace\u0219ti pacien\u021bi sunt \u00een chinuri f\u0103r\u0103 respectivul medicament. Fostul ministru v\u0103d c\u0103 arunc\u0103 vina pe al\u021bii, nu \u00ee\u0219i asum\u0103 responsabilitatea pentru lipsa medicamentului, de\u0219i am atras aten\u021bia \u00eenc\u0103 dinainte de \u00eencheierea mandatului ministrului c\u0103 nu au fost f\u0103cute demersurile necesare pentru multe medicamente \u0219i materiale sanitare lips\u0103 din sistem, mai ales din programele na\u021bionale\u201d, a precizat acesta.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Potrivit lui Vasile Barbu, criza s-a accentuat \u00eencep\u00e2nd cu toamna trecut\u0103, deoarece achizi\u021biile se fac pe termen lung, iar \u00een industrie au existat sincope de produc\u021bie din cauza lipsei de materie prim\u0103, a consumului ridicat de energie \u0219i gaze, a restructur\u0103rilor \u0219i a moderniz\u0103rii utilajelor, care implic\u0103 modific\u0103ri complexe ale fluxului tehnologic.\u00a0<\/p>\n<p>\u201eAceast\u0103 criz\u0103 s-a accentuat \u00eencep\u00e2nd cu toamna trecut\u0103, deoarece achizi\u021biile se fac, de regul\u0103, pe termen lung, dar au existat sincope \u00een produc\u021bie din cauza lipsei de materie prim\u0103, a consumului ridicat de energie \u0219i gaze, a restructur\u0103rilor \u0219i a moderniz\u0103rii utilajelor, care implic\u0103 modific\u0103ri complexe ale fluxului tehnologic. Aceste \u00eent\u00e2rzieri au generat crize reale de citostatice. \u00cen ceea ce prive\u0219te afirma\u021biile pre\u0219edintelui CNAS, nu le-am auzit integral, a\u0219a c\u0103 nu pot comenta \u00een detaliu asupra lor. \u0218tiu doar c\u0103 pacien\u021bii au c\u0103utat, \u00eentr-adev\u0103r, anumite citostatice, \u00een special cele off-label, care nu sunt prescrise uzual \u0219i care, de obicei, nu pot fi decontate dec\u00e2t \u00een baza unor hot\u0103r\u00e2ri judec\u0103tore\u0219ti, iar \u00een astfel de cazuri aprovizionarea prin Unifarm a \u00eent\u00e2mpinat dificult\u0103\u021bi.<\/p>\n<p> <a class=\"related-inline svelte-78g0vl\" data-gtrack=\"{&quot;event&quot;:&quot;utm_click&quot;,&quot;data&quot;:{&quot;event_category&quot;:&quot;article_related&quot;}}\" href=\"https:\/\/adevarul.ro\/stiri-interne\/sanatate\/tratament-cu-portia-sau-deloc-pentru-bolnavii-de-2526680.html\" title=\"Alt articol de interes pentru tine\" rel=\"nofollow noopener\" target=\"_blank\"> Tratament cu por\u021bia sau deloc pentru bolnavii de cancer: medicamentele inovatoare lipsesc din spitale <\/a><\/p>\n<p>Datele noastre arat\u0103 c\u0103 unele citostatice au lipsit \u00een anumite perioade, de\u0219i deficitul a fost adesea remediat rapid. \u00cen unele cazuri, pacien\u021bii au fost nevoi\u021bi s\u0103 cumpere medicamentele din Ungaria, Austria sau Germania, pl\u0103tind din fonduri proprii \u2013 o situa\u021bie care, \u00een opinia mea, este responsabilitatea Ministerului S\u0103n\u0103t\u0103\u021bii, \u00een special a direc\u021biei pharma care ar trebui s\u0103 coordoneze urgen\u021bele prin Unifarm, acolo unde s-a produs blocajul. De\u0219i am \u00een\u021beles c\u0103 domnul Cseke a \u00eencercat s\u0103 intervin\u0103, este deja t\u00e2rziu, iar recuperarea este dificil\u0103, deoarece comenzile \u0219i identificarea noilor furnizori dureaz\u0103 mult, mai ales c\u0103 ace\u0219tia nu sunt \u00eentotdeauna partenerii tradi\u021bionali ai distribuitorilor rom\u00e2ni\u201d, a explicat acesta.<\/p>\n<p> Bolnavii de cancer, printre victimele lipsei unui guvern cu puteri depline <\/p>\n<p>Vasile Barbu sus\u021bine c\u0103 \u00eent\u00e2rzierile aprovizion\u0103rii cu medicamente se prelungesc \u0219i din cauz\u0103, \u00een ultimele aproape 4 luni, nu am avut un Guvern cu puteri depline.<\/p>\n<p>\u201e\u00cen prezent, cauza principal\u0103 a \u00eent\u00e2rzierilor \u00een aprovizionarea cu medicamente este lipsa unui guvern cu puteri depline, care s\u0103 poat\u0103 realiza rectificarea bugetar\u0103 necesar\u0103 \u00een aceast\u0103 perioad\u0103 \u0219i specific\u0103 verii. Partea cu adev\u0103rat dificil\u0103 este c\u0103, \u00een lipsa unui guvern cu puteri depline, nu se poate realiza rectificarea bugetar\u0103, iar fondurile acumulate pentru s\u0103n\u0103tate \u2013 aproximativ 12 miliarde de lei r\u0103m\u00e2n blocate, de\u0219i dep\u0103\u0219esc veniturile estimate ini\u021bial prin legea bugetului.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>De asemenea, pentru a gr\u0103bi procesul, este nevoie de o serie de m\u0103suri complexe: modific\u0103ri legislative, hot\u0103r\u00e2ri de guvern \u0219i de ministru, decizii ale Agen\u021biei Na\u021bionale a Medicamentului, dar \u0219i de o evaluare riguroas\u0103 a tehnologiilor medicale pentru fiecare molecul\u0103 \u00een parte, ceea ce implic\u0103 numeroase etape. \u00cen acest timp, comisiile consultative de specialitate din cadrul Ministerului S\u0103n\u0103t\u0103\u021bii nu au func\u021bionat corespunz\u0103tor, iar fostul ministru Rogobete nu a avut o comunicare bun\u0103 cu acestea, ignor\u00e2nd propunerile noastre de a elabora protocoalele medicale \u00eempreun\u0103 cu Colegiul Medicilor \u0219i societ\u0103\u021bile profesionale, limit\u00e2nd astfel activitatea lor\u201d, a transmis acesta.<\/p>\n<p>Barbu a subliniat c\u0103, pentru a gr\u0103bi aprovizionarea, este nevoie de o serie de m\u0103suri complexe, care cuprind modific\u0103ri legislative, hot\u0103r\u00e2ri de guvern \u0219i de ministru, decizii ale Agen\u021biei Na\u021bionale a Medicamentului, dar \u0219i de o evaluare riguroas\u0103 a tehnologiilor medicale pentru fiecare molecul\u0103 \u00een parte.\u00a0<\/p>\n<p>\u201eF\u0103r\u0103 protocoale medicale care s\u0103 impun\u0103 utilizarea anumitor medicamente, nici Agen\u021bia Na\u021bional\u0103 a Medicamentului, nici distribuitorii nu sunt stimula\u021bi s\u0103 le autorizeze sau s\u0103 le aduc\u0103 \u00een stoc, mai ales c\u0103 acestea sunt extrem de costisitoare \u2013 de exemplu, o sut\u0103 de cutii de citostatic pot bloca fonduri suficiente pentru zece mii de alte cutii de medicamente. Problema este una complex\u0103, nu poate fi rezolvat\u0103 \u00een c\u00e2teva minute de discu\u021bie televizat\u0103, iar compara\u021bia cu alte \u021b\u0103ri relev\u0103 c\u0103, \u00een timp ce majoritatea statelor au termene de aprobare de aproximativ 300 de zile, Rom\u00e2nia se afl\u0103 sub aceast\u0103 medie.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>\u00cen plus, Agen\u021bia European\u0103 a Medicamentului a aprobat recent 47 de medicamente noi \u00eentr-un singur an, \u00eens\u0103 acestea \u00eent\u00e2rzie s\u0103 ajung\u0103 \u00een \u021bara noastr\u0103. De\u0219i unele sunt inovative \u0219i, prin urmare, scumpe, pe termen lung ele pot aduce economii semnificative, prin cre\u0219terea calit\u0103\u021bii vie\u021bii pacien\u021bilor \u0219i prin eficien\u021ba terapeutic\u0103 \u0219i economic\u0103 general\u0103. Din p\u0103cate, \u00een Rom\u00e2nia nu se fac astfel de calcule, iar aceste analize ar trebui s\u0103 fie o prioritate la Ministerul S\u0103n\u0103t\u0103\u021bii\u201d, a mai ar\u0103tat Vasile Barbu.<\/p>\n<p> Pacien\u021bii oncologici, \u00eentre tratamente am\u00e2nate \u0219i achizi\u021bii din fonduri proprii <\/p>\n<p>Mai multe medicamente esen\u021biale pentru tratamentul pacien\u021bilor oncologici sunt indisponibile \u00een aceast\u0103 perioad\u0103 \u00een unit\u0103\u021bile sanitare din Rom\u00e2nia, iar medicii sunt nevoi\u021bi, \u00een unele cazuri, s\u0103 am\u00e2ne administrarea tratamentelor sau s\u0103 modifice schemele terapeutice. De\u0219i \u00een cazul anumitor produse datele oficiale indic\u0103 existen\u021ba unor stocuri la nivel na\u021bional, acestea nu ajung \u00een spitale, iar pacien\u021bii \u0219i cadrele medicale reclam\u0103 o criz\u0103 real\u0103 de aprovizionare care afecteaz\u0103 direct calitatea actului medical.\u00a0<\/p>\n<p> <a class=\"related-inline svelte-78g0vl\" data-gtrack=\"{&quot;event&quot;:&quot;utm_click&quot;,&quot;data&quot;:{&quot;event_category&quot;:&quot;article_related&quot;}}\" href=\"https:\/\/adevarul.ro\/stiri-interne\/sanatate\/numarul-cazurilor-de-cancer-creste-alarmant-2533873.html\" title=\"Alt articol de interes pentru tine\" rel=\"nofollow noopener\" target=\"_blank\"> Num\u0103rul cazurilor de cancer cre\u0219te alarmant. Medicii avertizeaz\u0103: \u201eRisc\u0103m s\u0103 ne confrunt\u0103m cu o criz\u0103 oncologic\u0103 f\u0103r\u0103 precedent\u201d. <\/a><\/p>\n<p>Cel pu\u021bin trei medicamente utilizate \u00een tratamentul cancerului sau \u00een combaterea efectelor adverse provocate de tratamentele oncologice sunt semnalate ca fiind indisponibile, potrivit informa\u021biilor furnizate de medici \u0219i de asocia\u021biile de pacien\u021bi. \u00cen unele cazuri, lipsurile sunt semnalate \u00eenc\u0103 din luna iunie, iar livr\u0103rile ar putea fi reluate abia \u00een luna septembrie, din motive care \u021bin de procesele de fabrica\u021bie sau de \u00eentreruperi \u00een lan\u021burile de aprovizionare. Situa\u021bia este \u00eens\u0103 neomogen\u0103: \u00een timp ce unele produse nu sunt disponibile din cauza unor probleme de produc\u021bie, altele figureaz\u0103 \u00een stocurile prezentate pe site-ul Ministerului S\u0103n\u0103t\u0103\u021bii \u00een cantit\u0103\u021bi de peste 5.000 de unit\u0103\u021bi, dar nu se reg\u0103sesc \u00een spitale, ceea ce indic\u0103 o problem\u0103 de distribu\u021bie sau de alocare la nivelul unit\u0103\u021bilor sanitare.\u00a0<\/p>\n<p>Lipsa medicamentelor are consecin\u021be directe asupra pacien\u021bilor. Medicii spun c\u0103, \u00een asemenea situa\u021bii, sunt nevoi\u021bi s\u0103 am\u00e2ne administrarea tratamentului cu c\u00e2teva zile sau chiar pentru perioade mai lungi, iar acolo unde exist\u0103 alternative, pot modifica schema de tratament a pacientului. Problemele privesc at\u00e2t medicamente costisitoare, c\u00e2t \u0219i produse ieftine, iar unii pacien\u021bi ajung s\u0103 fie nevoi\u021bi s\u0103 \u00ee\u0219i cumpere singuri tratamentul, \u00eens\u0103 costurile pot deveni imposibil de suportat pe termen mai lung, \u00een special \u00een cazul medicamentelor off-label. Situa\u021bia este semnalat\u0103 at\u00e2t de pacien\u021bi \u0219i medici, c\u00e2t \u0219i de asocia\u021biile care \u00eei reprezint\u0103 pe bolnavii de cancer, care atrag aten\u021bia c\u0103 \u00eent\u00e2rzierile \u00een tratament pot avea consecin\u021be grave asupra evolu\u021biei bolii.\u00a0<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Nu este pentru prima dat\u0103 c\u00e2nd pacien\u021bii oncologici se confrunt\u0103 cu astfel de probleme. \u00cen ultimii ani, ace\u0219tia au reclamat periodic c\u0103 anumite medicamente necesare tratamentului nu mai sunt disponibile, iar criza actual\u0103, accentuat\u0103 de lipsa unui guvern cu puteri depline care s\u0103 poat\u0103 realiza rectificarea bugetar\u0103 necesar\u0103, a blocat fonduri importante destinate s\u0103n\u0103t\u0103\u021bii.<\/p>\n<p> Reprezentan\u021bii asocia\u021biilor pacien\u021bilor solicit\u0103 at\u00e2t deblocarea acestor fonduri, c\u00e2t \u0219i o mai bun\u0103 coordonare \u00eentre Ministerul S\u0103n\u0103t\u0103\u021bii, CNAS \u0219i Unifarm, pentru ca medicamentele s\u0103 ajung\u0103 la pacien\u021bi \u00een timp util \u0219i pentru ca tratamentele inovatoare, aprobate de Agen\u021bia European\u0103 a Medicamentului, s\u0103 nu mai \u00eent\u00e2rzie s\u0103 ajung\u0103 \u00een Rom\u00e2nia. P\u00e2n\u0103 atunci, pacien\u021bii oncologici r\u0103m\u00e2n expu\u0219i unor \u00eent\u00e2rzieri care le pot afecta semnificativ \u0219ansele de recuperare.\u00a0<\/p>\n<p> \\n  const _iprc = performance.now();\\n\\u003C\/script>\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221;>\\nconsole.log(\\&#8221;*** cookieconsent done:\\&#8221;, Math.round(performance.now() &#8211; _iprc) \/ 1000);\\n  gtag(&#8216;event&#8217;, &#8216;cookieconsent&#8217;, {\\n    name: &#8216;load&#8217;,\\n    value: Math.round(performance.now() &#8211; _iprc) \/ 1000\\n  });\\n\\u003C\/script>\\n\\u003C!&#8211; END PERFORMANCE COOKIE PRO &#8211;>\\n\\n{{#unless context.ads_disabled}}\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;\/\/a.teads.tv\/page\/99553\/tag\\&#8221; async=\\&#8221;true\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cdiv data-ad=\\&#8221;adevarul.ro_728x90_sticky_display_bottom_adevarul_bottom_center_leaderboard\\&#8221; data-devices=\\&#8221;m:0,t:1,d:1\\&#8221;   class=\\&#8221;demand-supply\\&#8221;>\\u003C\/div>\\n\\n{{#if context.content}}\\n\\n{{#unless context.ads_disabled}}\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;https:\/\/cnt.trvdp.com\/js\/1544\/6545.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\n{{\/if}}\\n\\n\\n&#8221;,&#8221;html_mobile&#8221;:&#8221;\\n\\n\\n\\u003C!&#8211; CHECK PERFORMANCE COOKIE PRO &#8211;>\\n\\u003Cscript>\\n  const _iprc = performance.now();\\n\\u003C\/script>\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221;>\\nconsole.log(\\&#8221;*** cookieconsent done:\\&#8221;, Math.round(performance.now() &#8211; _iprc) \/ 1000);\\n  gtag(&#8216;event&#8217;, &#8216;cookieconsent&#8217;, {\\n    name: &#8216;load&#8217;,\\n    value: Math.round(performance.now() &#8211; _iprc) \/ 1000\\n  });\\n\\u003C\/script>\\n\\u003C!&#8211; END PERFORMANCE COOKIE PRO &#8211;>\\n\\n{{#unless context.ads_disabled}}\\n\\n\\n\\u003Cscript\\n  class=\\&#8221;optanon-category-C0004\\&#8221;\\n  type=\\&#8221;text\/plain\\&#8221;\\n  src=\\&#8221;\/\/a.teads.tv\/page\/99553\/tag\\&#8221;\\n  async=\\&#8221;true\\&#8221;\\n>\\u003C\/script>\\n\\n{{\/unless}} \\n\\n\\u003Cdiv\\n  data-ad=\\&#8221;adevarul.ro_sticky_mobile_bottom\\&#8221;\\n  data-devices=\\&#8221;m:1,t:0,d:0\\&#8221;\\n  class=\\&#8221;demand-supply\\&#8221;\\n>\\u003C\/div>\\n\\n{{#if context.content}} \\n\\n\\n{{#unless context.ads_disabled}}\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;https:\/\/cnt.trvdp.com\/js\/1544\/6545.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n{{\/if}}\\n\\n&#8221;},&#8221;updated_at&#8221;:&#8221;2025-11-01T11:31:21.462Z&#8221;},&#8221;AdPosition_head&#8221;:{&#8222;data&#8221;:{&#8222;custom_fields&#8221;:{},&#8221;for_desktop&#8221;:true,&#8221;for_mobile&#8221;:true,&#8221;html_desktop&#8221;:&#8221;\\u003Cmeta name=\\&#8221;profitshareid\\&#8221; content=\\&#8221;934cd37887433d585a2a227ef0576fcc\\&#8221; \/>\\n\\n\\n\\n{{#unless context.ads_disabled}}\\n\\n\\n{{#if context.content}}\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/jsc.mgid.com\/site\/960965.js\\&#8221; async>\\u003C\/script>\\n\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221;>\\n  (function () {\\n    if (document.location.pathname.indexOf(&#8222;https:\/\/adevarul.ro\/ghid-de-cumparaturi&#8221;) === 0) {\\n      return;\\n    }\\n\\n    const s = document.createElement(\\&#8221;script\\&#8221;);\\n    s.src = \\&#8221;https:\/\/srv.divee.ai\/storage\/v1\/object\/public\/sdk\/divee.sdk.latest.js\\&#8221;;\\n    s.setAttribute(\\&#8221;data-project-id\\&#8221;, \\&#8221;4428864e-2da6-4fef-a83c-c16c2dfe86d9\\&#8221;);\\n    s.async = true;\\n    document.head.appendChild(s);\\n  })();\\n\\u003C\/script>\\n\\n\\n\\n\\n\\n{{\/if}}\\n\\n\\u003Cscript>\\n  window.teads_analytics = window.teads_analytics || {};\\n  window.teads_analytics.analytics_tag_id = \\&#8221;PUB_26459\\&#8221;;\\n  window.teads_analytics.share = window.teads_analytics.share || function() {\\n    ;(window.teads_analytics.shared_data = window.teads_analytics.shared_data || []).push(arguments)\\n  };\\n\\u003C\/script>\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/a.teads.tv\/analytics\/tag.js\\&#8221;>\\u003C\/script>\\n\\n\\n{{#unless context.features.nolivesupply}}\\n\\u003Cscript async data-cfasync=\\&#8221;false\\&#8221; type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/live.demand.supply\/up.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3345426167175409\\&#8221; crossorigin=\\&#8221;anonymous\\&#8221;>\\u003C\/script>\\n\\n \\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/terrific.live\/terrific-sdk.js\\&#8221; storeid=\\&#8221;iN6X0VPTDIicsVPKX6p0\\&#8221;>\\u003C\/script>\\n\\n{{\/unless}}\\n\\n\\u003Cstyle>\\n.google-adposition > div {\\n  flex-grow: 1;\\n}\\n\\n.google-adposition:has(iframe) {\\n    background-image: none !important;\\n}\\n\\n.menu-fixed .menu .headContainer .google-auto-placed {\\n    display: none;\\n}\\n\\narticle header .title .google-auto-placed {\\n    display: none;\\n}\\n\\n#onetrust-banner-sdk #onetrust-accept-btn-handler {\\n        margin-bottom: 10px;\\n    }\\n\\n    #onetrust-banner-sdk #onetrust-reject-all-handler {\\n        visibility: hidden;\\n    }\\n\\n\\u003C\/style>\\n\\n \\u003C!&#8211; Facebook Pixel Code &#8211;>\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0002\\&#8221;>!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=&#8217;2.0&#8242;;n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,document,&#8217;script&#8217;,&#8217;https:\/\/connect.facebook.net\/en_US\/fbevents.js&#8217;); fbq(&#8216;init&#8217;, &#8216;1346397800155390&#8217;); fbq(&#8216;track&#8217;, &#8216;PageView&#8217;);\\u003C\/script>\\u003Cnoscript> \\u003Cimg height=\\&#8221;1\\&#8221; width=\\&#8221;1\\&#8221; src=\\&#8221;https:\/\/www.facebook.com\/tr?id=1346397800155390&#038;ev=PageView&#038;noscript=1\\&#8221;\/>\\u003C\/noscript>\\u003C!&#8211; End Facebook Pixel Code &#8211;>\\n\\n\\u003C!&#8211; alternativeAds &#8211;>\\n&#8221;,&#8221;html_mobile&#8221;:&#8221;\\u003Cmeta name=\\&#8221;profitshareid\\&#8221; content=\\&#8221;934cd37887433d585a2a227ef0576fcc\\&#8221; \/>\\n\\n\\n{{#unless context.ads_disabled}}\\n\\n{{#if context.content}}\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/jsc.mgid.com\/site\/960965.js\\&#8221; async>\\u003C\/script>\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221;>\\n  (function () {\\n    if (document.location.pathname.indexOf(&#8222;https:\/\/adevarul.ro\/ghid-de-cumparaturi&#8221;) === 0) {\\n      return;\\n    }\\n\\n    const s = document.createElement(\\&#8221;script\\&#8221;);\\n    s.src = \\&#8221;https:\/\/srv.divee.ai\/storage\/v1\/object\/public\/sdk\/divee.sdk.latest.js\\&#8221;;\\n    s.setAttribute(\\&#8221;data-project-id\\&#8221;, \\&#8221;4428864e-2da6-4fef-a83c-c16c2dfe86d9\\&#8221;);\\n    s.async = true;\\n    document.head.appendChild(s);\\n  })();\\n\\u003C\/script>\\n\\n{{\/if}}\\n\\n\\u003Cscript>\\n  window.teads_analytics = window.teads_analytics || {};\\n  window.teads_analytics.analytics_tag_id = \\&#8221;PUB_26459\\&#8221;;\\n  window.teads_analytics.share = window.teads_analytics.share || function() {\\n    ;(window.teads_analytics.shared_data = window.teads_analytics.shared_data || []).push(arguments)\\n  };\\n\\u003C\/script>\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/a.teads.tv\/analytics\/tag.js\\&#8221;>\\u003C\/script>\\n\\n{{#unless context.features.nolivesupply}}\\n\\u003Cscript async data-cfasync=\\&#8221;false\\&#8221; type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/live.demand.supply\/up.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/terrific.live\/terrific-sdk.js\\&#8221; storeid=\\&#8221;iN6X0VPTDIicsVPKX6p0\\&#8221;>\\u003C\/script>\\n\\n{{\/unless}}\\n\\u003Cstyle>\\n\\n.google-adposition:has(iframe) {\\n    background-image: none !important;\\n}\\n\\n.menu-fixed .menu .headContainer .google-auto-placed {\\n    display: none;\\n}\\n\\narticle header .title .google-auto-placed {\\n    display: none;\\n}\\n\\n#onetrust-banner-sdk #onetrust-accept-btn-handler {\\n        margin-bottom: 10px;\\n    }\\n\\n    #onetrust-banner-sdk #onetrust-reject-all-handler {\\n        visibility: hidden;\\n    }\\n\\u003C\/style>\\n&#8221;},&#8221;updated_at&#8221;:&#8221;2026-07-22T15:44:05.196Z&#8221;}},&#8221;last_changed&#8221;:&#8221;2026-08-26T19:32:10.414Z&#8221;,&#8221;page&#8221;:{&#8222;created_at&#8221;:&#8221;2026-08-19T18:57:11.447Z&#8221;,&#8221;created_by&#8221;:1,&#8221;custom_fields&#8221;:{},&#8221;domain&#8221;:&#8221;adevarul.ro&#8221;,&#8221;id&#8221;:99,&#8221;last_published_at&#8221;:&#8221;2026-08-19T18:57:12.918Z&#8221;,&#8221;name&#8221;:&#8221;Content layout (article)&#8221;,&#8221;published&#8221;:1,&#8221;s3_hash&#8221;:&#8221;a5e0764cf3bce051367545eab1538b4619e8ecb9&#8243;,&#8221;slug&#8221;:null,&#8221;title&#8221;:&#8221;Content layout&#8221;,&#8221;type&#8221;:&#8221;layout&#8221;,&#8221;updated_at&#8221;:&#8221;2022-07-21T08:27:20.732Z&#8221;,&#8221;version_id&#8221;:271},&#8221;path&#8221;:&#8221;\/stiri-interne\/sanatate\/nu-va-puneti-prin-inactiune-semnatura-pe-2552104.html&#8221;,&#8221;pathArray&#8221;:[&#8222;&#8221;,&#8221;stiri-interne&#8221;,&#8221;sanatate&#8221;,&#8221;nu-va-puneti-prin-inactiune-semnatura-pe-2552104.html&#8221;],&#8221;type&#8221;:&#8221;content&#8221;,&#8221;url&#8221;:&#8221;https:\/\/adevarul.ro\/stiri-interne\/sanatate\/nu-va-puneti-prin-inactiune-semnatura-pe-2552104.html&#8221;,&#8221;features&#8221;:{},&#8221;query&#8221;:{},&#8221;domain_config&#8221;:{&#8222;MISC&#8221;:{&#8222;logo&#8221;:{&#8222;width&#8221;:320,&#8221;height&#8221;:50}},&#8221;SYSTEM_TAGS&#8221;:[&#8222;noads&#8221;,&#8221;nocomments&#8221;,&#8221;sex&#8221;,&#8221;advert&#8221;,&#8221;advertorial&#8221;,&#8221;video&#8221;,&#8221;galerie&#8221;,&#8221;live&#8221;,&#8221;foto&#8221;,&#8221;exclusiv&#8221;,&#8221;analiza&#8221;,&#8221;interviu&#8221;,&#8221;reportaj&#8221;,&#8221;breaking news&#8221;],&#8221;default&#8221;:{&#8222;lang&#8221;:&#8221;ro&#8221;,&#8221;domain&#8221;:&#8221;adevarul.ro&#8221;,&#8221;alternateDomain&#8221;:&#8221;adevarul-ro.adh.reperio.news&#8221;,&#8221;friendlyName&#8221;:&#8221;Adev\u0103rul&#8221;,&#8221;logoURL&#8221;:&#8221;https:\/\/adevarul.ro\/favicon-144-precomposed.png&#8221;}},&#8221;client&#8221;:{&#8222;is_mobile&#8221;:false}}<\/p>\n","protected":false},"excerpt":{"rendered":"Declara\u021bia pre\u0219edintelui CNAS, Hora\u021biu Moldovan, potrivit c\u0103reia medicamentele pentru bolnavii de cancer sunt disponibile este contrazis\u0103 de asocia\u021biile&hellip;\n","protected":false},"author":2,"featured_media":277040,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[1126,60915,32,33,532,4478,76444,31,76208,76442,36,37,76443,27,491,34,35,1385,76441,25,2103,41,40,38,39,26,28,29,30],"class_list":["post-277039","post","type-post","status-publish","format-standard","has-post-thumbnail","category-titluri","tag-analiza","tag-bolnavi-de-cancer","tag-breaking-news","tag-breakingnews","tag-cancer","tag-casa-nationala-de-asigurari-de-sanatate","tag-case-nationale-de-asigurari-de-sanatate","tag-cele-mai-populare-subiecte","tag-citostatice","tag-criza-medicamente","tag-featured-news","tag-featurednews","tag-federatia-asociatiilor-bolnavilor-de-cancer","tag-headlines","tag-horatiu-moldovan","tag-latest-news","tag-latestnews","tag-medicamente","tag-medicamente-oncologie","tag-news","tag-rectificare-bugetara","tag-ro","tag-romana","tag-romania","tag-romanian","tag-stiri","tag-titluri","tag-top-stories","tag-topstories"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/277039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/comments?post=277039"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/277039\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media\/277040"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media?parent=277039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/categories?post=277039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/tags?post=277039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}